FEB 10, 2020 6:24 PM PST

Drug Prevents Coronavirus in Monkeys

WRITTEN BY: Nouran Amin

An antiviral drug successfully prevented Middle East respiratory syndrome coronavirus (MERS-CoV) in infected rhesus macaques. The drug, Remdesivir, was administered in the macaques before infection and improved their condition after infection. These findings are according to a new report from the NIH's National Institute of Allergy and Infectious Diseases (NIAID) and is published in the Proceedings of the National Academy of Sciences.

Learn more about the coronavirus:

MERS-CoV is similar to the 2019 novel coronavirus (SARS-CoV-2) that first emerged as a public health crisis in Wuhan, China. Previous studies observed the protection of animals against a variety of viral infections due to Remdesivir administration. Now, it was shown to experimentally treat monkeys with Ebola and Nipah viruses.

The present study investigated animals for six days that were 1) treated with remdesivir 24 hours before infection with MERS-CoV 2) those treated 12 hours after infection and 3) untreated control animals that showed signs of respiratory disease. The pre-infection animals had no signs of respiratory disease and no lung damage along with low levels of virus replication in the lungs in comparison to the control animals. For animals treated after infection, symptoms of the disease were less severe than in control animals.

The promising findings of the study encourage researches to push for clinical trials of remdesivir for MERS-CoV and COVID-19, the disease that SARS-CoV-2 causes. In fact, several studies for clinical trials of remdesivir for COVID-19 are under way in China, and other patients with COVID-19 have received the drug under a compassionate use protocol.

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
SEP 20, 2020
Drug Discovery & Development
Cholesterol-Lowering Drugs Reduce The Severity of COVID-19
SEP 20, 2020
Cholesterol-Lowering Drugs Reduce The Severity of COVID-19
Almost a year into the beginnings of the COVID-19 pandemic and we still do not have a Food and Drug Administration (FDA) ...
SEP 21, 2020
Drug Discovery & Development
Metformin Does Not Work in All Type 2 Diabetics
SEP 21, 2020
Metformin Does Not Work in All Type 2 Diabetics
Although metformin is the first-line drug for type-2 diabetics, research shows that it is not always effective for all t ...
OCT 12, 2020
Drug Discovery & Development
In vitro glycoengineering - Suitability for BioPharma manufacturing
OCT 12, 2020
In vitro glycoengineering - Suitability for BioPharma manufacturing
Introduction The importance of Fc glycosylation of monoclonal antibodies (mAbs) with regard to biological activity is wi ...
NOV 08, 2020
Cell & Molecular Biology
Mouth Spray for Epidermolysis Bullosa in Development
NOV 08, 2020
Mouth Spray for Epidermolysis Bullosa in Development
Epidermolysis Bullosa (EB) is a rare genetic disorder that makes the skin incredibly fragile; it forms blisters and can ...
NOV 09, 2020
Drug Discovery & Development
New Immunotherapy Shows Promise for MS
NOV 09, 2020
New Immunotherapy Shows Promise for MS
Researchers from Thomas Jefferson University in Philadelphia are studying an immunotherapy that has shown early pro ...
NOV 26, 2020
Drug Discovery & Development
Sestrin Increases the Lifespan of Fruit Flies
NOV 26, 2020
Sestrin Increases the Lifespan of Fruit Flies
Reduced food intake, known as dietary restriction, leads to a longer lifespan in many animals and can improve health in ...
Loading Comments...